{"createdAt":"8/2/2020, 2:08:32 PM","timestamp":1596391712763,"Company ID number":"353","DMX_ISSUER_NAME":"JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.","DMX_ISSUER_ID":"IID000000002196596","Country of Classification":"CHINA","name":"Jiangsu Yuyue Medical Equipment & Supply Co Ltd ","code":"002223","stock_exchange":"Shenzhen Stock Exchange","people":[{"id":"江苏鱼跃医疗设备股份有限公司_吴光明","group":"board","name":"吴光明","title":"董事长,董事","isMale":true,"age":"58","degree":"本科","salary":"94.86万","stockAmount":"1.034亿","description":"吴光明,男,1962年出生,高级经济师、高级工程师,现任江苏鱼跃医疗设备股份有限公司董事长兼总经理、中国医疗器械协会副会长。1997年毕业于江苏理工大学,2010年进入中欧国际工商学院学习。曾任丹阳城镇医疗电子仪器厂厂长、丹阳医用器械厂厂长,1998年至今,担任江苏鱼跃医疗设备股份有限公司董事长兼总经理。","lastUpdated":"2016-10-27"},{"id":"江苏鱼跃医疗设备股份有限公司_吴群","group":"board","name":"吴群","title":"副董事长,董事","isMale":true,"age":"32","degree":"硕士","salary":"277.4万","stockAmount":"7739万","description":"吴群,男,生于1988年,硕士研究生学历,曾任职苏州索尼液晶显示器有限公司生产企划部担任经理助理职务,现任苏州医云健康管理有限公司CEO,江苏鱼跃医疗设备股份有限公司副董事长兼总裁,2018年至今任职北京万东医疗科技股份有限公司副董事长。","lastUpdated":"2019-04-18"},{"id":"江苏鱼跃医疗设备股份有限公司_陈坚","group":"board","name":"陈坚","title":"董事","isMale":true,"age":"52","degree":"本科","salary":"105.3万","stockAmount":"-","description":"陈坚先生:1968年出生,大学本科学历,经济师职称。曾任职于中共上海市委,并历任万科股份有限公司销售策划,协和药业有限公司上海办主任,养生堂有限责任公司销管中心经理兼销售总监,2004年至今任职于江苏鱼跃医疗设备股份有限公司,历任总经理助理兼人力资源部经理,副总经理,现任江苏鱼跃医疗设备股份有限公司董事、副总经理兼董事会秘书。","lastUpdated":"2016-10-27"},{"id":"江苏鱼跃医疗设备股份有限公司_景国民","group":"board","name":"景国民","title":"董事","isMale":true,"age":"56","degree":"大专","salary":"74.16万","stockAmount":"-","description":"景国民先生:1964年出生,大专学历,中共党员,工程师职称。曾担任丹棉集团化纤纺织分厂动力车间负责人,担任丹阳市顺达线厂企业管理工作。2003年进入江苏鱼跃医疗设备股份有限公司,历任综合分厂厂长,监事,现任江苏鱼跃医疗设备股份有限公司董事、副总经理并任江苏鱼跃医疗设备股份有限公司全资子公司苏州医疗用品厂有限公司总经理。","lastUpdated":"2016-10-27"},{"id":"江苏鱼跃医疗设备股份有限公司_郑洪喆","group":"board","name":"郑洪喆","title":"董事","isMale":true,"age":"38","degree":"硕士","salary":"91.68万","stockAmount":"-","description":"郑洪喆:男,1982年出生,生物医学工程硕士学历,曾任深圳迈瑞生物医疗电子股份有限公司超声产品事业部需求工程师、产品经理;现任江苏鱼跃医疗设备股份有限公司董事、战略资讯部经理。","lastUpdated":"2016-10-27"},{"id":"江苏鱼跃医疗设备股份有限公司_王千华","group":"board","name":"王千华","title":"独立董事","isMale":true,"age":"48","degree":"博士","salary":"8.150万","stockAmount":"-","description":"王千华先生,1972年出生,中国国籍,无境外永久居留权,博士研究生学历。1999年至今,在深圳大学法学院、港澳基本法研究中心工作,从事国际经济法、合同法和港澳法的教学科研工作,法学教授,硕士研究生导师,兼职律师。王先生目前还担任贵州泰永长征技术股份有限公司的独立董事和江苏鱼跃医疗设备股份有限公司的独立董事。王先生自2015年8月起担任公司独立董事。现任深圳市东方嘉盛供应链股份有限公司独立董事,贵州泰永长征技术股份有限公司独立董事。","lastUpdated":"2016-10-27"},{"id":"江苏鱼跃医疗设备股份有限公司_李祖滨","group":"board","name":"李祖滨","title":"独立董事","isMale":true,"age":"51","degree":"硕士","salary":"8.150万","stockAmount":"-","description":"李祖滨:男,1969年5月出生,中国国籍,无境外居留权,研究生学历。主要工作经历:2001年7月至2002年5月,历任深圳泰思微科技有限公司南京分公司经理、工程师;2002年6月至2003年5月,任马勒发动机零部件(南京)有限公司人力资源部经理;2003年5月至2004年7月,任深圳沃尔玛百货零售有限公司薪酬福利经理;2004年8月至2005年3月,任上海拓晟管理咨询有限公司项目经理;2005年4月至2010年11月,历任上海智比企业管理咨询有限公司执行董事、总经理;2010年7月至2012年6月,历任南京丰盛产业控股集团执行总裁、副总裁;2012年3月至今,历任上海德至锐泽企业管理咨询有限公司执行董事、总经理;兼任华培动力、鱼跃医疗独立董事。","lastUpdated":"2016-10-27"},{"id":"江苏鱼跃医疗设备股份有限公司_陈平","group":"board","name":"陈平","title":"独立董事","isMale":true,"age":"59","degree":"硕士","salary":"8.150万","stockAmount":"-","description":"陈平先生,1961年5月生,中国国籍,无永久境外居留权,1983年武汉理工大学管理工程专业毕业,获学士学位。1983年到江苏大学任教。1996年江苏大学工商学院研究生毕业获经济学硕士学位。中国注册会计师协会非执业会员,副教授,硕士生导师。主持完成国家科委课题。参与江苏省社科课题、机械部科研课题、国资委科研课题多项,获机械部、中国工商联合会奖项多项。在各专业核心期刊发表论文30多篇。目前从事会计与财务管理专业教学与研究,任江苏大学财经学院财务与会计研究所所长,兼任江苏鱼跃医疗设备股份有限公司和江苏索普化工股份有限公司独立董事。","lastUpdated":"2016-10-27"},{"id":"江苏鱼跃医疗设备股份有限公司_殷国贞","group":"supervisoryCommittee","name":"殷国贞","title":"监事会主席","isMale":true,"age":"54","degree":"高中","salary":"74.29万","stockAmount":"-","description":"殷国贞先生:1966年出生,高中学历,中共党员。曾任丹阳县行宫农机具修造厂技术员、团支部书记,丹阳市医疗器械模具工、技术科长,1998年至今任职江苏鱼跃医疗设备股份有限公司,历任轮椅分厂技术员、技术科长,现任江苏鱼跃医疗设备股份有限公司监事会主席兼轮椅分厂厂长。","lastUpdated":"2016-10-27"},{"id":"江苏鱼跃医疗设备股份有限公司_徐坤峰","group":"supervisoryCommittee","name":"徐坤峰","title":"监事","isMale":true,"age":"50","degree":"本科","salary":"46.55万","stockAmount":"-","description":"徐坤峰先生:1970年出生,本科学历。曾任职国有新曹第二机械厂、国有新曹丝绸总厂、苏州上稳摄影器材有限公司、苏州新吴机械电子有限公司、特莫瓦特(无锡)电器工业有限公司--阿里斯顿热能集团,现担任公司监事及子公司苏州医疗用品厂有限公司技术副总经理。","lastUpdated":"2016-10-27"},{"id":"江苏鱼跃医疗设备股份有限公司_陈建军","group":"supervisoryCommittee","name":"陈建军","title":"监事","isMale":true,"age":"40","degree":"本科","salary":"72.02万","stockAmount":"-","description":"陈建军先生:1980年出生,本科学历。2003年毕业于浙江大学生物技术专业。曾任职艾康生物技术(杭州)有限公司任血糖生产技术主管,2010年入职江苏鱼跃医疗设备股份有限公司,现担任江苏鱼跃医疗设备股份有限公司监事及公司血糖技术部高级工程师。","lastUpdated":"2016-10-27"},{"id":"江苏鱼跃医疗设备股份有限公司_吕占斌","group":"supervisoryCommittee","name":"吕占斌","title":"监事","isMale":true,"age":"37","degree":"本科","salary":"74.70万","stockAmount":"-","description":"吕占斌先生:1983年出生,本科学历,毕业于大连理工大学电子信息工程专业。曾任职于深圳迈瑞医疗电子生物股份有限公司国际营销系统,2010年加盟鱼跃集团,先后在江苏鱼跃医疗设备股份有限公司任市场部经理、国际销售部经理、项目部总监等职,现担任子公司西藏鱼跃医疗设备开发有限公司总经理。","lastUpdated":"2016-10-27"},{"id":"江苏鱼跃医疗设备股份有限公司_曹炀","group":"supervisoryCommittee","name":"曹炀","title":"监事","isMale":true,"age":"72","degree":"硕士","salary":"116.4万","stockAmount":"-","description":"曹炀先生:男,1948年出生,研究生学历,高级经济师职称。曾任苏州医疗用品厂厂长、书记。苏州医疗用品厂有限公司董事长、总经理。2009年鱼跃医疗收购苏州医疗用品厂有限公司后担任苏州医疗用品厂有限公司董事长至今,现任江苏鱼跃医疗设备股份有限公司监事。","lastUpdated":"2016-10-27"},{"id":"江苏鱼跃医疗设备股份有限公司_蔡林泉","group":"supervisoryCommittee","name":"蔡林泉","title":"职工监事","isMale":true,"age":"47","degree":"中专","salary":"60.07万","stockAmount":"660","description":"蔡林泉先生:1973年出生,中专学历。曾先后任职于江苏先锋集团江阴先锋电脑有限公司、武进市齐力电子技术有限公司、常州泰格电子有限公司。现任江苏鱼跃医疗设备股份有限公司监事兼公司研发中心项目经理。","lastUpdated":"2016-10-27"},{"id":"江苏鱼跃医疗设备股份有限公司_顾惠萍","group":"supervisoryCommittee","name":"顾惠萍","title":"职工监事","isMale":false,"age":"54","degree":"本科","salary":"31.71万","stockAmount":"-","description":"顾惠萍:1966年出生,女,中国国籍,高级政工师,上海医疗器械专科学校精密医疗仪器专业毕业,上海市委党校行政管理专业本科毕业。顾惠萍女士历任上海医疗器械(集团)有限公司手术器械厂工会副主席、行政条线分管负责人、工会主席;现任上海医疗器械(集团)有限公司手术器械厂工会主席。","lastUpdated":"2016-10-27"},{"id":"江苏鱼跃医疗设备股份有限公司_吴群","group":"manager","name":"吴群","title":"总经理","isMale":true,"age":"32","degree":"硕士","salary":"277.4万","stockAmount":"7739万","description":"吴群,男,生于1988年,硕士研究生学历,曾任职苏州索尼液晶显示器有限公司生产企划部担任经理助理职务,现任苏州医云健康管理有限公司CEO,江苏鱼跃医疗设备股份有限公司副董事长兼总裁,2018年至今任职北京万东医疗科技股份有限公司副董事长。","lastUpdated":"2019-04-18"},{"id":"江苏鱼跃医疗设备股份有限公司_陈坚","group":"manager","name":"陈坚","title":"董事会秘书,副总经理","isMale":true,"age":"52","degree":"本科","salary":"105.3万","stockAmount":"-","description":"陈坚先生:1968年出生,大学本科学历,经济师职称。曾任职于中共上海市委,并历任万科股份有限公司销售策划,协和药业有限公司上海办主任,养生堂有限责任公司销管中心经理兼销售总监,2004年至今任职于江苏鱼跃医疗设备股份有限公司,历任总经理助理兼人力资源部经理,副总经理,现任江苏鱼跃医疗设备股份有限公司董事、副总经理兼董事会秘书。","lastUpdated":"2016-10-27"},{"id":"江苏鱼跃医疗设备股份有限公司_景国民","group":"manager","name":"景国民","title":"副总经理","isMale":true,"age":"56","degree":"大专","salary":"74.16万","stockAmount":"-","description":"景国民先生:1964年出生,大专学历,中共党员,工程师职称。曾担任丹棉集团化纤纺织分厂动力车间负责人,担任丹阳市顺达线厂企业管理工作。2003年进入江苏鱼跃医疗设备股份有限公司,历任综合分厂厂长,监事,现任江苏鱼跃医疗设备股份有限公司董事、副总经理并任江苏鱼跃医疗设备股份有限公司全资子公司苏州医疗用品厂有限公司总经理。","lastUpdated":"2016-10-27"},{"id":"江苏鱼跃医疗设备股份有限公司_吕英芳","group":"manager","name":"吕英芳","title":"副总经理","isMale":true,"age":"53","degree":"本科","salary":"84.61万","stockAmount":"-","description":"吕英芳先生:1967年出生,本科学历。曾任职丹阳城镇医疗电子仪器厂销售科长,1998年至今任职于江苏鱼跃医疗设备股份有限公司,历任销售科长,内销部经理,销售总监兼华北区大区经理,监事会主席,现任江苏鱼跃医疗设备股份有限公司北方大区销售经理、公司副总经理。","lastUpdated":"2016-10-27"},{"id":"江苏鱼跃医疗设备股份有限公司_毛坚强","group":"manager","name":"毛坚强","title":"副总经理","isMale":true,"age":"55","degree":"本科","salary":"210.5万","stockAmount":"-","description":"毛坚强先生:1965年出生,本科学历,工程师。曾任丹阳柴油机厂车间主任、技术科长,2001年起任职于江苏鱼跃医疗设备股份有限公司,曾任江苏鱼跃医疗设备股份有限公司医电分厂厂长,江苏鱼跃医疗设备股份有限公司监事会主席(已辞去监事职务),现任江苏鱼跃医疗设备股份有限公司副总经理。","lastUpdated":"2016-10-27"},{"id":"江苏鱼跃医疗设备股份有限公司_欧阳东锦","group":"manager","name":"欧阳东锦","title":"副总经理","isMale":true,"age":"57","degree":"本科","salary":"83.45万","stockAmount":"-","description":"欧阳东锦先生:1963年出生,本科学历。曾任丹阳眼镜总厂生产科长,1998年至今任职于江苏鱼跃医疗设备股份有限公司,现任江苏鱼跃医疗设备股份有限公司副总经理。","lastUpdated":"2016-10-27"},{"id":"江苏鱼跃医疗设备股份有限公司_眭秀华","group":"manager","name":"眭秀华","title":"副总经理","isMale":true,"age":"51","degree":"硕士","salary":"83.95万","stockAmount":"-","description":"眭秀华先生:1969年出生,EMBA,1998年任职于江苏鱼跃医疗设备股份有限公司,历任销售员,市场部经理,健康事业部总经理,现任江苏鱼跃医疗设备股份有限公司董事长办公室主任,公司副总经理。","lastUpdated":"2016-10-27"},{"id":"江苏鱼跃医疗设备股份有限公司_郁雄峰","group":"manager","name":"郁雄峰","title":"副总经理","isMale":true,"age":"41","degree":"硕士","salary":"54.20万","stockAmount":"-","description":"郁雄峰先生:1979年出生,中共党员,EMBA硕士。先后任职江苏鱼跃医疗设备股份有限公司担任轮椅车分厂技术员,公司子公司丹阳真木君洋医疗器械有限公司总经理,公司轮椅车事业部经理,现任江苏鱼跃医疗设备股份有限公司监事兼康复护理事业部经理。","lastUpdated":"2016-10-27"},{"id":"江苏鱼跃医疗设备股份有限公司_赵帅","group":"manager","name":"赵帅","title":"副总经理","isMale":true,"age":"39","degree":"硕士","salary":"177.1万","stockAmount":"-","description":"赵帅先生:1981年出生,工学硕士、高级工商管理硕士(EMBA),工程师职称。曾任深圳华为技术有限公司采购工程师、中东/中亚地区采购经理。2009年至今任职于江苏鱼跃医疗设备股份有限公司,历任供应链管理部经理、总经理秘书、总经理助理,现任子公司苏州医疗用品厂有限公司及苏州鱼跃科技发展有限公司董事长,公司副总经理。","lastUpdated":"2016-10-27"},{"id":"江苏鱼跃医疗设备股份有限公司_赵春生","group":"manager","name":"赵春生","title":"副总经理","isMale":true,"age":"48","degree":"硕士","salary":"128.1万","stockAmount":"-","description":"赵春生先生:1972年出生,男,中国国籍,工程师,上海交通大学工商管理硕士,吉林工业大学工学硕士.赵春生先生历任上海医疗器械(集团)有限公司总经理助理、副总经理,从事技术和战略发展管理;曾任华润万东医疗装备有限公司董事、上海医疗器械厂有限公司总经理,现任上海医疗器械(集团)有限公司总经理。","lastUpdated":"2016-10-27"},{"id":"江苏鱼跃医疗设备股份有限公司_刘丽华","group":"manager","name":"刘丽华","title":"财务负责人","isMale":false,"age":"42","degree":"硕士","salary":"79.24万","stockAmount":"-","description":"刘丽华女士:1978年出生,EMBA,会计师职称。曾先后任职于江苏丹棉集团、江苏恒宝股份有限公司,2006年至今任职于江苏鱼跃医疗设备股份有限公司,曾任财务部副经理,现任江苏鱼跃医疗设备股份有限公司财务负责人。","lastUpdated":"2016-10-27"}],"companyName":"江苏鱼跃医疗设备股份有限公司","province":"江苏省","englishName":"Jiangsu Yuyue Mdcl Eqpmnt & Spply Co Ltd","industry":"医药生物 — 医疗器械Ⅱ","website":"www.yuyue.com.cn","mainBusiness":"医疗器械和保健用品的生产和销售。","productsName":["医用呼吸与供氧","医用临床","家用医疗","外贸产品"],"actualController":"吴光明","actualControllerSharePercentage":"33.63%","registeredCapital":"10.02亿元","employeeAmount":"5005","phone":"86-0511-86900876","location":"江苏省镇江市丹阳市云阳工业园(振新路南)","chineseDescription":"江苏鱼跃医疗设备股份有限公司是一家以提供家用医疗器械、医用临床产品以及与之相关的医疗服务为主要业务的公司,研发、制造和销售医疗器械产品及提供相关解决方案是公司核心业务,也是公司主要业绩来源。公司产品主要集中在呼吸供氧、血压血糖、消毒感控、医疗急救、手术器械、中医器械、眼科器械、康复护理、隐形眼镜及提供医院消毒感染控制解决方案等领域。“金钟”品牌,主要用于医用手术器械产品,“金钟”品牌具有80多年的悠久历史,是“上海市著名商标”,在国内手术器械领域具有较高的知名度和影响力。“洁芙柔”、“安尔碘”系全资子公司上海中优品牌,已成为国内医院感染和控制领域的第一品牌。","foundedDate":"1998-10-22","goPublicDate":"2008-04-18","companyHistory":"江苏鱼跃医疗设备股份有限公司(以下简称―本公司,在包含子公司时统称―本集团),前身是1998年10月22日经江苏省工商行政管理局核准成立的江苏鱼跃医疗设备有限公司,2007年6月15日根据江苏鱼跃医疗设备有限公司2007年临时股东会决议、发起人协议、公司章程的规定,江苏鱼跃医疗设备有限公司依法整体变更为江苏鱼跃医疗设备股份有限公司。\n  2008年4月8日经中国证券监督管理委员会―证监许可(2008)415号《关于核准江苏鱼跃医疗设备股份有限公司首次公开发行股票的批复》文件的核准,本公司向社会公开发行人民币普通股2,600万股(每股面值1元),增加股本人民币26,000,000.00元,变更后的股本为人民币103,000,000.00元,并于2008年4月18日在深圳证券交易所上市交易。\n  经历次转增、增发,截至2015年12月31日,本公司的股本为人民币584,767,040.00元。\n  2016年6月8日经中国证券监督管理委员会―证监许可(2016)877号《关于核准江苏鱼跃医疗设备股份有限公司非公开发行股票的批复》,本公司非公开发行人民币普通股(A股)83,550,913.00股,每股面值1元,每股发行价格为人民币30.64元。变更后的股本为人民币668,317,953.00元。\n  2017年5月25日根据本公司2016年度股东大会审议通过2016年年度权益分派方案,本公司以2016年度末股本668,317,953.00股为基数,以资本公积每10股转增5股,向全体股东实施分配,合计增加股本334,158,976.00元,变更后的股本为人民币1,002,476,929.00元。\n  经历次转增、增发,截至2019年6月30日,本公司的股本为人民币1,002,476,929.00元。收起▲","shareholders":[{"organizationId":"03148871","holderName":"江苏鱼跃科技发展有限公司","totalShare":"2.66亿","sharePercentage":"26.53%"},{"organizationId":"","holderName":"吴光明","totalShare":"1.03亿","sharePercentage":"10.32%"},{"organizationId":"","holderName":"吴群","totalShare":"7738.98万","sharePercentage":"7.72%"},{"organizationId":"","holderName":"全国社保基金一一三组合","totalShare":"3311.09万","sharePercentage":"3.30%"},{"organizationId":"","holderName":"兴业银行股份有限公司-兴全趋势投资混合型证券投资基金","totalShare":"2567.71万","sharePercentage":"2.56%"},{"organizationId":"T000125370","holderName":"香港中央结算有限公司","totalShare":"2412.95万","sharePercentage":"2.41%"},{"organizationId":"","holderName":"全国社保基金四一八组合","totalShare":"2197.12万","sharePercentage":"2.19%"},{"organizationId":"","holderName":"基本养老保险基金八零二组合","totalShare":"1840.01万","sharePercentage":"1.84%"},{"organizationId":"","holderName":"兴业银行股份有限公司-兴全新视野灵活配置定期开放混合型发起式证券投资基金","totalShare":"1260.92万","sharePercentage":"1.26%"},{"organizationId":"","holderName":"中信证券-中信银行-中信证券卓越成长股票集合资产管理计划","totalShare":"898.73万","sharePercentage":"0.90%"}],"englishDescription":"JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. is a China-based company, principally engaged in the research and development, manufacture and distribution of medical equipment. The Company provides rehabilitation nursing products, medical oxygen supply products and medical clinical equipment series, including medical electronic equipment, medical diagnostic and rehabilitation equipment, medical image equipment, wheelchairs/walking aid products, electronic blood pressure monitors, oxygen inhalators, as well as gynecological and obstetrical instruments, among others. It distributes its products within domestic market and to overseas markets.","englishIndustry":"Medical Equipment & Supplies","Price to earnings (ttm)":"41.49","Price to sales (ttm)":"7.64","Price to book (mrq)":"5.71","Price to cash flow (ttm)":"--","Total debt to equity (mrq)":"5.95","Lt debt to equity (mrq)":"1.55","Return on investment (ttm)":"14.04","Return on equity (ttm)":"11.28","Income statement":{"Revenue":"4,635.93","Total revenue":"4,635.93","Cost of revenue, total":"2,690.91","Gross profit":"1,945.03","Selling/general/admin. expenses, total":"905.09","Research & development":"213.57","Depreciation/amortization":"62.31","Interest exp.(inc.),net-operating, total":"(33.12)","Unusual expense (income)":"(0.50)","Other operating expenses, total":"(52.21)","Total operating expense":"3,786.05","Operating income":"849.89","Gain (loss) on sale of assets":"(1.99)","Other, net":"16.45","Net income before taxes":"864.34","Provision for income taxes":"102.77","Net income after taxes":"761.57","Minority interest":"(9.01)","Net income before extra. items":"752.57","Net income":"752.57","Income available to com excl extraord":"752.57","Income available to com incl extraord":"752.57","Diluted net income":"752.57","Diluted weighted average shares":"1,002.48","Diluted eps excluding extraord items":"0.75","Dps - common stock primary issue":"0.40","Diluted normalized eps":"0.75"},"Balance sheet":{"Cash":"0.62","Cash & equivalents":"1,562.47","Short term investments":"1.00","Cash and short term investments":"1,564.09","Accounts receivable - trade, net":"974.26","Total receivables, net":"1,425.45","Total inventory":"926.09","Prepaid expenses":"236.38","Other current assets, total":"9.10","Total current assets":"4,161.12","Property/plant/equipment, total - gross":"2,551.40","Accumulated depreciation, total":"(555.56)","Property/plant/equipment, total - net":"1,995.85","Goodwill, net":"736.33","Intangibles, net":"589.13","Long term investments":"383.37","Other long term assets, total":"99.93","Total assets":"7,965.73","Accounts payable":"942.35","Accrued expenses":"115.10","Notes payable/short term debt":"195.05","Other current liabilities, total":"322.68","Total current liabilities":"1,575.18","Long term debt":"0.00","Total long term debt":"0.00","Total debt":"195.05","Deferred income tax":"42.57","Minority interest":"86.00","Other liabilities, total":"191.40","Total liabilities":"1,895.15","Common stock, total":"1,002.48","Additional paid-in capital":"1,783.96","Retained earnings (accumulated deficit)":"3,279.66","Other equity, total":"4.48","Total equity":"6,070.58","Total liabilities & shareholders' equity":"7,965.73","Total common shares outstanding":"1,002.48","Tangible book value per share, common eq":"4.73","Current port. of  lt debt/capital leases":"100.00"},"Cash flow":{"Cash receipts":"4,010.31","Cash payments":"(2,088.64)","Cash taxes paid":"(233.21)","Changes in working capital":"(1,074.26)","Cash from operating activities":"614.20","Capital expenditures":"(440.39)","Other investing cash flow items, total":"(112.78)","Cash from investing activities":"(553.17)","Total cash dividends paid":"(159.26)","Issuance (retirement) of debt, net":"(6.94)","Cash from financing activities":"(166.20)","Foreign exchange effects":"7.10","Net change in cash":"(98.06)","Financing cash flow items":"2.00"},"keyMetrics":{"Price and Volume":{"Price closing or last bid":"36.78","52 Week High":"41.91","52 Week Low":"18.20","Pricing date":"","10 Day Average Trading Volume":"30.68","Market Capitalization":"36,871.10","52 Week High Date":"","52 Week Low Date":"","3 Month Average Trading Volume":"787.68","Beta":"0.90","1 Day Price Change":"0.99","13 Week Price Return (Daily)":"5.99","26 Week Price Return (Daily)":"50.68","5 Day Price Return (Daily)":"6.83","52 Week Price Return (Daily)":"61.67","Year To Date Price Return (Daily)":"81.00","Month to Date Price Return (Daily)":"1.04","Price Relative to S&P500 (4 Week)":"-7.06","Price Relative to S&P500 (13 Week)":"-16.67","Price Relative to S&P500 (26 Week)":"18.02","Price Relative to S&P500 (52 Week)":"9.87","Price Relative to S&P500 (YTD)":"38.44"},"Per Share Data":{"EPS excl. Extra Items (Annual)":"0.75","EPS excl. Extra Items (TTM)":"0.89","EPS Normalized (Annual)":"0.75","Revenue per Share (Annual)":"4.62","Revenue per Share (TTM)":"4.81","Book Value (Per Share Annual)":"6.06","Book Value (Per Share Quarterly)":"6.44","Tangible Book Value (Per Share Annual)":"4.73","Tangible Book Value (Per Share Quarterly)":"4.99","Cash Per Share (Per Share Annual)":"1.56","Cash Per Share (Per Share Quarterly)":"1.63","Cash Flow (Per Share Annual)":"0.86","Cash Flow (Per Share TTM)":"--","Dividend (Per Share Annual)":"0.40","Dividends (Per Share TTM)":"0.40","EBITD (Per Share TTM)":"0.95","EPS Basic excl. Extra Items (Annual)":"0.75","EPS Basic excl. Extra Items (TTM)":"0.89","EPS incl. Extra Items (Annual)":"0.75","EPS incl. Extra Items (TTM)":"0.89","Free Cash Flow (Per Share TTM)":"1.07","Dividend (Per Share 5Y)":"0.25"},"Valuation":{"P/E excl. Extra Items (Annual)":"48.99","P/E excl. Extra Items (TTM)":"41.49","P/E Normalized (Annual)":"48.91","Price to sales (Annual)":"7.95","Price to sales (TTM)":"7.64","Price to Tangible Book (Annual)":"7.77","Price to Tangible Book (Quarterly)":"7.37","Price to Free Cash Flow (Per Share Annual)":"2,532.96","Price to Cash Flow (Per Share TTM)":"--","Price to Free Cash Flow (Per Share TTM)":"34.52","Price to Book (Annual)":"6.07","Price to Book (Quarterly)":"5.71","P/E Basic excl. Extra Items (TTM)":"40.93","P/E excl. Extra Items High (TTM)":"110.13","P/E excl. Extra Items Low (TTM)":"26.67","P/E incl. Extra Items (TTM)":"41.49","Net Debt (Interim)":"-1,250.67","Net Debt (Annual)":"-1,369.05","Dividend Yield (5Y)":"1.17","Dividend Yield":"1.09","Current Dividend Yield (TTM)":"1.09"},"Financial Strength":{"Free Cash Flow (Annual)":"14.56","Current Ratio (Annual)":"2.64","Net Interest coverage (Annual)":"--","Long Term Debt/Equity (Annual)":"0.00","Payout Ratio (Annual)":"53.28","Quick Ratio (Annual)":"2.05","Total Debt/Total Equity (Annual)":"3.21","Current EV/Free Cash Flow (Annual)":"138.18","Current EV/Free Cash Flow (TTM)":"--","Current Ratio (Quarterly)":"2.37","Long Term Debt/Equity (Quarterly)":"1.55","Quick Ratio (Quarterly)":"1.88","Total Debt/Total Equity (Quarterly)":"5.95","Free Cash Flow (TTM)":"1,068.21","Net Interest Coverage (TTM)":"--","Payout Ratio (TTM)":"45.13"},"Margins":{"Gross Margin (Annual)":"41.96","Gross Margin (TTM)":"44.78","Net Profit Margin % (Annual)":"16.43","Net Profit Margin (TTM)":"18.56","Operating Margin (Annual)":"18.33","Operating Margin (TTM)":"20.92","Pretax Margin (TTM)":"21.29","Pretax Margin (Annual)":"18.64","Operating Margin (5Y)":"18.84","Pretax Margin (5Y)":"19.94","Free Operating Cash Flow/Revenue (5Y)":"2.77","Free Operating Cash Flow/Revenue (TTM)":"22.14","Gross Margin (5Y)":"40.14","Net Profit Margin (5Y)":"17.58"},"Management Effectiveness":{"Return on Assets (Annual)":"10.24","Return on Equity (TTM)":"11.28","Return on Average Equity (Annual)":"13.04","Return on Average equity (TTM)":"14.57","Return on Investment (Annual)":"12.69","Return on Investment (TTM)":"14.04","Return on Average Assets (5Y)":"11.00","Return on Average Equity (5Y)":"13.56","Return on Investment (5Y)":"13.32","Asset Turnover (Annual)":"0.62","Asset Turnover (TTM)":"0.61","Inventory Turnover (Annual)":"3.40","Inventory Turnover (TTM)":"3.35","Net Income/Employee (Annual)":"154,243.00","Net Income/Employee (TTM)":"178,954.40","Receivables Turnover (Annual)":"5.10","Receivables Turnover (TTM)":"4.50","Revenue/Employee (Annual)":"938,923.50","Revenue/Employee (TTM)":"964,180.00"},"Growth":{"Revenue Growth (Quarterly YoY)":"15.80","Revenue Growth Rate (5Y)":"22.48","EPS Growth (Quarterly YoY)":"55.16","EPS Growth (TTM YoY)":"16.91","EPS Growth Rate (5Y)":"17.26","Dividend Growth Rate (3Y)":"14.47","Revenue Growth (TTM YoY)":"11.11","Revenue Growth (Per Share 5Y)":"19.25","Revenue Growth Rate (3Y)":"20.64","EPS Growth Rate (3Y)":"12.30","Book Value Growth Rate (Per Share 5Y)":"24.86","Tangible Book Value Total Equity CAGR (5Y)":"23.35","Capital Spending growth rate 5 year":"24.68","EBITDA CAGR (5Y)":"23.52","EBITDA Interim CAGR (5Y)":"25.90","Free Operating Cash Flow CAGR (5Y)":"29.79","Total Debt CAGR (5Y)":"22.75","Net Profit Margin Growth Rate (5Y)":"-1.49"},"Income Statement":{"Revenue (Annual)":"4,635.94","Revenue (TTM)":"4,825.72","EBITD (Annual)":"911.89","EBITD (TTM)":"957.06","Earnings Before Taxes (Annual)":"864.34","Earnings Before Taxes (TTM)":"1,027.63","Net Income to Common (Annual)":"752.57","Net Income to Common (TTM)":"888.59","Earnings Before Taxes Normalized (Annual)":"865.83","Net Income Available to Common Normalized (Annual)":"753.88","Diluted Normalized EPS excl. Extra Items (TTM)":"0.89"}}}